PARIS, Jan 8 (Reuters) - French pharmaceutical group Sanofi said it has obtained the right to develop and sell a new hemophilia drug in a restructuring of its partnership with U.S. Alnylam Pharmaceuticals.

by support@endlesssupplies.biz (Endless Supplies .Biz) via Endless Supplies .Biz - News

by support@endlesssupplies.biz (Endless Supplies .Biz) via EndlessSupplies.Biz
No comments:
Post a Comment